Inhibition of glutaminyl cyclase attenuates cell migration modulated by monocyte chemoattractant proteins

Biochemical Journal

Volumn 442, Issue 2, 2012, Pages 403-412

  Chen, Yi Ling ^a,b,c   Huang, Kai Fa ^b,c   Kuo, Wen Chih ^b   Lo, Yan Chung ^a,b,c   Lee, Yu May ^b   Wang, Andrew H J ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

Author keywords

Chemokine; Glutaminyl cyclase (QC); Lipopolysaccharide (LPS); Monocyte; Monocyte chemoattractant protein (MCP); Pyroglutamate (pGlu)

Indexed keywords

ENZYME; ENZYME INHIBITOR; GLUTAMINYL CYCLASE; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; PBD 150; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG TARGETING; ENZYME INHIBITION; INFLAMMATION; MASS SPECTROMETRY; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MONOCYTE; PRIORITY JOURNAL;

AMINOACYLTRANSFERASES; BASE SEQUENCE; CELL MOVEMENT; ENZYME INHIBITORS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MODELS, MOLECULAR; MONOCYTE CHEMOATTRACTANT PROTEINS; MONOCYTES; PROTEIN INTERACTION DOMAINS AND MOTIFS; RNA, SMALL INTERFERING; U937 CELLS;

EID: 84863169850     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110535     Document Type: Article

References (48)

1. Busby, W. H., Quackenbush, G. E., Humm, J., Youngblood, W. W. and Kizer, J. S. (1987) An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes. J. Biol. Chem. 262, 8532-8536
2. Fischer, W. H. and Spiess, J. (1987) Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides. Proc. Natl. Acad. Sci. U.S.A. 84, 3628-3632 (Pubitemid 17088334)
3. Huang, K. F., Liu, Y. L. and Wang, A. H. (2005) Cloning, expression, characterization, and crystallization of a glutaminyl cyclase from human bone marrow: a single zinc metalloenzyme. Protein Expression Purif. 43, 65-72
4. Schilling, S., Manhart, S., Hoffmann, T., Ludwig, H. H., Wasternack, C. and Demuth, H. U. (2003) Substrate specificity of glutaminyl cyclases from plants and animals. Biol. Chem. 384, 1583-1592 (Pubitemid 38054881)
5. Goren, H. J., Bauce, L. G. and Vale, W. (1977) Forces and structural limitations of binding of thyrotrophin-releasing factor to thyrotrophin- releasing receptor: the pyroglutamic acid moiety. Mol. Pharmacol. 13, 606-614 (Pubitemid 8148877)
6. Van Coillie, E., Proost, P., Van Aelst, I., Struyf, S., Polfliet, M., De Meester, I., Harvey, D. J., Van Damme, J. and Opdenakker, G. (1998) Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry 37, 12672-12680 (Pubitemid 28427552)
7. Cynis, H., Rahfeld, J. U., Stephan, A., Kehlen, A., Koch, B., Wermann, M., Demuth, H. U. and Schilling, S. (2008) Isolation of an isoenzyme of human glutaminyl cyclase: retention in the Golgi complex suggests involvement in the protein maturation machinery. J. Mol. Biol. 379, 966-980
8. Huang, K. F., Liaw, S. S., Huang, W. L., Chia, C. Y., Lo, Y. C., Chen, Y. L. and Wang, A. H. J. (2011) Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding. J. Biol. Chem. 286, 12439-12449
9. Chikuma, T., Taguchi, K., Yamaguchi, M., Hojo, H. and Kato, T. (2004) Improved determination of bovine glutaminyl cyclase activity using precolumn derivatization and reversed-phase high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 806, 113-118 (Pubitemid 38686497)
10. Muthusamy, V., Duraisamy, S., Bradbury, C. M., Hobbs, C., Curley, D. P., Nelson, B. and Bosenberg, M. (2006) Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res. 66, 11187-11193 (Pubitemid 46009946)
11. Schilling, S., Zeitschel, U., Hoffmann, T., Heiser, U., Francke, M., Kehlen, A., Holzer, M., Hutter-Paier, B., Prokesch, M., Windisch, M. et al. (2008) Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology. Nat. Med. 14, 1106-1111
12. Ezura, Y., Kajita, M., Ishida, R., Yoshida, S., Yoshida, H., Suzuki, T., Hosoi, T., Inoue, S., Shiraki, M., Orimo, H. and Emi, M. (2004) Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women. J. Bone Miner. Res. 19, 1296-1301 (Pubitemid 41094371)
13. Batliwalla, F. M., Baechler, E. C., Xiao, X., Li, W., Balasubramanian, S., Khalili, H., Damle, A., Ortmann, W., Perrone, A., Kantor, A. B. et al. (2005) Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun. 6, 388-397 (Pubitemid 43090514)
14. N3(pE), in senile plaques. Neuron 14, 457-466
15. Harigaya, Y., Saido, T. C., Eckman, C. B., Prada, C. M., Shoji, M. and Younkin, S. G. (2000) Amyloid β protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Biochem. Biophys. Res. Commun. 276, 422-427
16. Schilling, S., Appl, T., Hoffmann, T., Cynis, H., Schulz, K., Jagla, W., Friedrich, D., Wermann, M., Buchholz, M., Heiser, U. et al. (2008) Inhibition of glutaminyl cyclase prevents pGlu-Aβ formation after intracortical/ hippocampal microinjection in vivo/in situ. J. Neurochem. 106, 1225-1236
17. Schilling, S., Niestroj, A. J., Rahfeld, J. U., Hoffmann, T., Wermann, M., Zunkel, K., Wasternack, C. and Demuth, H. U. (2003) Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators. J. Biol. Chem. 278, 49773-49779 (Pubitemid 37548810)
18. Buchholz, M., Heiser, U., Schilling, S., Niestroj, A. J., Zunkel, K. and Demuth, H. U. (2006) The first potent inhibitors for human glutaminyl cyclase: synthesis and structure - activity relationship. J. Med. Chem. 49, 664-677 (Pubitemid 43157496)
19. Cynis, H., Schilling, S., Bodnar, M., Hoffmann, T., Heiser, U., Saido, T. C. and Demuth, H. U. (2006) Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells. Biochim. Biophys. Acta 1764, 1618-1625 (Pubitemid 44548538)
20. Sozzani, S., Locati, M., Allavena, P., Van Damme, J. and Mantovani, A. (1996) Chemokines: a superfamily of chemotactic cytokines. Int. J. Clin. Lab. Res. 26, 69-82 (Pubitemid 26310342)
21. Jin, T., Xu, X. H. and Hereld, D. (2008) Chemotaxis, chemokine receptors and human disease. Cytokine 44, 1-8
22. Proost, P., Wuyts, A. and VanDamme, J. (1996) Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J. Leukocyte Biol. 59, 67-74 (Pubitemid 26054592)
23. Gong, J. H. and Clark-Lewis, I. (1995) Antagonists of monocyte chemoattractant protein-1 identified by modification of functionally critical Nh2-terminal residues. J. Exp. Med. 181, 631-640
24. Proost, P., Struyf, S., Couvreur, M., Lenaerts, J. P., Conings, R., Menten, P., Verhaert, P., Wuyts, A. and Van Damme, J. (1998) Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor. J. Immunol. 160, 4034-4041 (Pubitemid 28176113)
25. Zhang, Y. J. and Rollins, B. J. (1995) A dominant-negative inhibitor indicates that monocyte chemoattractant protein-1 functions as a dimer. Mol. Cell. Biol. 15, 4851-4855
26. Schilling, S., Hoffmann, T., Wermann, M., Heiser, U., Wasternack, C. and Demuth, H. U. (2002) Continuous spectrometric assays for glutaminyl cyclase activity. Anal. Biochem. 303, 49-56 (Pubitemid 34271104)
27. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S. et al. (1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 905-921
28. Luthy, R., Bowie, J. U. and Eisenberg, D. (1992) Assessment of protein models with three-dimensional profiles. Nature 356, 83-85
29. Laskowski, R. A., Moss, D. S. and Thornton, J. M. (1993) Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 231, 1049-1067 (Pubitemid 23209879)
30. Huang, K. F., Liu, Y. L., Cheng, W. J., Ko, T. P. and Wang, A. H. (2005) Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation. Proc. Natl. Acad. Sci. U.S.A. 102, 13117-13122
31. Hemmerich, S., Paavola, C., Bloom, A., Bhakta, S., Freedman, R., Grunberger, D., Krstenansky, J., Lee, S., McCarley, D., Mulkins, M. et al. (1999) Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry 38, 13013-13025
32. Simmonds, R. E. and Foxwell, B. M. (2008) Signalling, inflammation and arthritis: NF-κB and its relevance to arthritis and inflammation. Rheumatology 47, 584-590 (Pubitemid 351619194)
33. Van Damme, J., Proost, P., Put, W., Arens, S., Lenaerts, J. P., Conings, R., Opdenakker, G., Heremans, H. and Billiau, A. (1994) Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J. Immunol. 152, 5495-5502 (Pubitemid 24152999)
34. Walsh, C. T., Garneau-Tsodikova, S. and Gatto, G. J. (2005) Protein posttranslational modifications: the chemistry of proteome diversifications. Angew. Chem. Int. Ed. 44, 7342-7372 (Pubitemid 41689988)
35. Boler, J., Enzmann, F., Folkers, K., Bowers, C. Y. and Schally, A. V. (1969) Identity of chemical and hormonal properties of thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem. Biophys. Res. Commun. 37, 705-710
36. Nillni, E. A., Friedman, T. C., Todd, R. B., Birch, N. P., Loh, Y. P. and Jackson, I. M. D. (1995) Pro-thyrotropin-releasing hormone processing by recombinant Pc1. J. Neurochem. 65, 2462-2472
37. Blaszczyk, J., Van Coillie, E., Proost, P., Van Damme, J., Opdenakker, G., Bujacz, G. D., Wang, J. M. and Ji, X. (2000) Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry 39, 14075-14081
38. Abraham, G. N. and Podell, D. N. (1981) Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal. Mol. Cell. Biochem. 38, 181-190 (Pubitemid 12250053)
39. Lubkowski, J., Bujacz, G., Boque, L., Domaille, P. J., Handel, T. M. and Wlodawer, A. (1997) The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat. Struct. Biol. 4, 64-69 (Pubitemid 27020927)
40. Meunier, S., Bernassau, J. M., Guillemot, J. C., Ferrara, P. and Darbon, H. (1997) Determination of the three-dimensional structure of CC chemokine monocyte chemoattractant protein 3 by 1H two-dimensional NMR spectroscopy. Biochemistry 36, 4412-4422 (Pubitemid 27180287)
41. Barinka, C., Prahl, A. and Lubkowski, J. (2008) Structure of human monocyte chemoattractant protein 4 (MCP-4/CCL13). Acta Crystallogr. Sect. D Biol. Crystallogr. 64, 273-278 (Pubitemid 351348053)
42. Clark-Lewis, I., Kim, K. S., Rajarathnam, K., Gong, J. H., Dewald, B., Moser, B., Baggiolini, M. and Sykes, B. D. (1995) Structure-activity relationships of chemokines. J. Leukocyte Biol. 57, 703-711
43. Schilling, S., Kohlmann, S., Bäuscher, C., Sedlmeier, R., Koch, B., Eichentopf, R., Becker, A., Cynis, H., Hoffmann, T., Berg, S. et al. (2011) Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug development. J. Biol. Chem. 286, 14199-14208
44. Cynis, H., Hoffmann, T., Friedrich, D., Kehlen, A., Gans, K., Kleinschmidt, M., Rahfeld, J. U., Wolf, R., Wermann, M., Stephan, A. et al. (2011) The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions. EMBO Mol. Med. 3, 545-558
45. Yan, L., Anderson, G. M., DeWitte, M. and Nakada, M. T. (2006) Therapeutic potential of cytokine and chemokine antagonists in cancer therapy. Eur. J. Cancer 42, 793-802
46. Furuya, M., Yonemitsu, Y. and Aoki, I. (2009) III. Angiogenesis: complexity of tumor vasculature and microenvironment. Curr. Pharm. Des. 15, 1854-1867
47. D'Souza, M. P. and Harden, V. A. (1996) Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat. Med. 2, 1293-1300 (Pubitemid 26401723)
48. Princen, K. and Schols, D. (2005) HIV chemokine receptor inhibitors as novel anti-HIV drugs. Cytokine Growth Factor Rev. 16, 659-677 (Pubitemid 41505522)